Desert King
  • Nosotros
  • Materias Primas
    • Administración de Materias Primas: Quillaja
    • Administración de Materias Primas: Yucca
    • Administración de Materias Primas: Jojoba
  • Líneas de Negocio
    • Farmacéutica
    • Nutrición y Salud Animal
    • Alimentación y Bebidas
    • Cuidado Personal y Cosmética
    • Agricultura
    • Medio ambiente y minería
  • Calidad
  • Noticias
  • Canal de Denuncias
  • Contacto
  • Inglés
  • Español
La Opción Natural La Opción Natural La Opción Natural La Opción Natural
  • Nosotros
  • Materias Primas
    • Administración de Materias Primas: Quillaja
    • Administración de Materias Primas: Yucca
    • Administración de Materias Primas: Jojoba
  • Líneas de Negocio
    • Farmacéutica
    • Nutrición y Salud Animal
    • Alimentación y Bebidas
    • Cuidado Personal y Cosmética
    • Agricultura
    • Medio ambiente y minería
  • Calidad
  • Noticias
  • Canal de Denuncias
  • Contacto
  • Inglés
  • Español

Sin categorizar

Adeagbo, B.A., et al. Lyophilization Strategy Enhances the Thermostability and Field-Based Stability of Conjugated and Comixed Subunit Liposomal Adjuvant-containing Tuberculosis Vaccine Formulation (ID93 + GLA-LSQ).
0
By Desert King
In Sin categorizar
Posted 9 mayo, 2025

Adeagbo, B.A., et al. Lyophilization Strategy Enhances the Thermostability and Field-Based Stability of Conjugated and Comixed Subunit Liposomal Adjuvant-containing Tuberculosis Vaccine Formulation (ID93 + GLA-LSQ).

Adeagbo, B.A., et al. Lyophilization Strategy Enhances the Thermostability and Field-Based Stability of Conjugated and Comixed Subunit Liposomal Adjuvant-containing Tuberculosis Vaccine [...]

READ MORE
Madden, P.J., et al. Diverse priming outcomes under conditions of very rare precursor B cells.
0
By Desert King
In Sin categorizar
Posted 9 mayo, 2025

Madden, P.J., et al. Diverse priming outcomes under conditions of very rare precursor B cells.

Madden, P.J., et al. Diverse priming outcomes under conditions of very rare precursor B cells. Immunity, 2025 Apr 8, 58(4):997-1014.e11. PMID: 40168992 The paper investigates the recruitment and [...]

READ MORE
Song, Y., et al.  50-Fold Adjuvant and 20-Fold Antigen Vaccine Dose Sparing from Nanoliposome Display of a Stabilized Malarial Protein Antigen.
0
By Desert King
In Sin categorizar
Posted 9 mayo, 2025

Song, Y., et al. 50-Fold Adjuvant and 20-Fold Antigen Vaccine Dose Sparing from Nanoliposome Display of a Stabilized Malarial Protein Antigen.

Song, Y., et al.  50-Fold Adjuvant and 20-Fold Antigen Vaccine Dose Sparing from Nanoliposome Display of a Stabilized Malarial Protein Antigen. CS Nano, 2025 Mar 18, 19(10):10103-10112. PMID: [...]

READ MORE
Pal, P.B. and Lyer, S.S. Transient pain and long-term gain: adjuvant dose directs immune memory.
0
By Desert King
In Sin categorizar
Posted 9 mayo, 2025

Pal, P.B. and Lyer, S.S. Transient pain and long-term gain: adjuvant dose directs immune memory.

Pal, P.B. and Lyer, S.S. Transient pain and long-term gain: adjuvant dose directs immune memory. J Clin Invest, 2025 Apr 15, 135(8):e190524. PMID: 40231461 The paper discusses the role of saponin [...]

READ MORE
Ramezani-Rad, P., et al. The saponin monophosphoryl lipid A nanoparticle adjuvant induces dose-dependent HIV vaccine responses in nonhuman primates.
0
By Desert King
In Sin categorizar
Posted 9 mayo, 2025

Ramezani-Rad, P., et al. The saponin monophosphoryl lipid A nanoparticle adjuvant induces dose-dependent HIV vaccine responses in nonhuman primates.

Ramezani-Rad, P., et al. The saponin monophosphoryl lipid A nanoparticle adjuvant induces dose-dependent HIV vaccine responses in nonhuman primates. J Clin Invest, 2025 Mar 4, 135(8):e185292. [...]

READ MORE
Leroux-Roels, I., et al. Safety and Immunogenicity of an Adjuvanted Clostridioides difficile Vaccine Candidate in Healthy Adults: A Randomized Placebo-Controlled Phase 1 Study.
0
By Desert King
In Sin categorizar
Posted 9 mayo, 2025

Leroux-Roels, I., et al. Safety and Immunogenicity of an Adjuvanted Clostridioides difficile Vaccine Candidate in Healthy Adults: A Randomized Placebo-Controlled Phase 1 Study.

Leroux-Roels, I., et al. Safety and Immunogenicity of an Adjuvanted Clostridioides difficile Vaccine Candidate in Healthy Adults: A Randomized Placebo-Controlled Phase 1 Study. J Infect Dis, 2025 [...]

READ MORE
Ison, M.G., et al. Efficacy, safety, and immunogenicity of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over three respiratory syncytial virus seasons (AReSVi-006): a multicentre, randomised, observer-blinded, placebo-controlled, phase 3 trial.
0
By Desert King
In Sin categorizar
Posted 9 mayo, 2025

Ison, M.G., et al. Efficacy, safety, and immunogenicity of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over three respiratory syncytial virus seasons (AReSVi-006): a multicentre, randomised, observer-blinded, placebo-controlled, phase 3 trial.

Ison, M.G., et al. Efficacy, safety, and immunogenicity of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over three respiratory [...]

READ MORE
Ye, L., et al. Effects of immune response on different nano-adjuvants combined with H11 antigen of Haemonchus contortus.
0
By Desert King
In Sin categorizar
Posted 18 marzo, 2025

Ye, L., et al. Effects of immune response on different nano-adjuvants combined with H11 antigen of Haemonchus contortus.

The study indicates that nano-adjuvants offer a promising alternative to traditional adjuvants for inducing robust and lasting immune responses

READ MORE

DESERT KING INTERNATIONAL
745 Main Street-
Chula Vista, CA, USA, 91911
+1 619 429 5222
info@desertking.com

DESERT KING CHILE
Avenida Industrial 1970
Quilpué, Chile, 2420505
+56 32 292 5020
info@desertking.cl

DESERT KING MEXICO
Camino Vecinal 11500-A
Tijuana B.C., México, 22664
+52 664 636 11 24
info@desertkingmexico.com

© 2025 Desert King. All Right Reserved

Start typing and press Enter to search